148 related articles for article (PubMed ID: 21321361)
1. Promotion and maintenance of leukemia by ERG.
Tsuzuki S; Taguchi O; Seto M
Blood; 2011 Apr; 117(14):3858-68. PubMed ID: 21321361
[TBL] [Abstract][Full Text] [Related]
2. ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells.
Stankiewicz MJ; Crispino JD
Blood; 2009 Apr; 113(14):3337-47. PubMed ID: 19168790
[TBL] [Abstract][Full Text] [Related]
3. Transposon mutagenesis reveals cooperation of ETS family transcription factors with signaling pathways in erythro-megakaryocytic leukemia.
Tang JZ; Carmichael CL; Shi W; Metcalf D; Ng AP; Hyland CD; Jenkins NA; Copeland NG; Howell VM; Zhao ZJ; Smyth GK; Kile BT; Alexander WS
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6091-6. PubMed ID: 23533276
[TBL] [Abstract][Full Text] [Related]
4. Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia.
Goldberg L; Tijssen MR; Birger Y; Hannah RL; Kinston SJ; Schütte J; Beck D; Knezevic K; Schiby G; Jacob-Hirsch J; Biran A; Kloog Y; Marcucci G; Bloomfield CD; Aplan PD; Pimanda JE; Göttgens B; Izraeli S
Blood; 2013 Oct; 122(15):2694-703. PubMed ID: 23974202
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia.
Carmichael CL; Metcalf D; Henley KJ; Kruse EA; Di Rago L; Mifsud S; Alexander WS; Kile BT
Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15437-42. PubMed ID: 22936051
[TBL] [Abstract][Full Text] [Related]
6. ERG is a megakaryocytic oncogene.
Salek-Ardakani S; Smooha G; de Boer J; Sebire NJ; Morrow M; Rainis L; Lee S; Williams O; Izraeli S; Brady HJ
Cancer Res; 2009 Jun; 69(11):4665-73. PubMed ID: 19487285
[TBL] [Abstract][Full Text] [Related]
7. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
[TBL] [Abstract][Full Text] [Related]
8. The proto-oncogene ERG in megakaryoblastic leukemias.
Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
[TBL] [Abstract][Full Text] [Related]
9. Perturbation of fetal hematopoiesis in a mouse model of Down syndrome's transient myeloproliferative disorder.
Birger Y; Goldberg L; Chlon TM; Goldenson B; Muler I; Schiby G; Jacob-Hirsch J; Rechavi G; Crispino JD; Izraeli S
Blood; 2013 Aug; 122(6):988-98. PubMed ID: 23719302
[TBL] [Abstract][Full Text] [Related]
10. Cytarabine and EIP co-administration synergistically reduces viability of acute lymphoblastic leukemia cells with high ERG expression.
Cheng L; Zeng S; Yan D; Tu L; Yang Y; Wang X; Zheng X
Leuk Res; 2021 Oct; 109():106649. PubMed ID: 34271301
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias.
Tursky ML; Beck D; Thoms JA; Huang Y; Kumari A; Unnikrishnan A; Knezevic K; Evans K; Richards LA; Lee E; Morris J; Goldberg L; Izraeli S; Wong JW; Olivier J; Lock RB; MacKenzie KL; Pimanda JE
Leukemia; 2015 Apr; 29(4):819-27. PubMed ID: 25306899
[TBL] [Abstract][Full Text] [Related]
12. Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells.
Xie Y; Koch ML; Zhang X; Hamblen MJ; Godinho FJ; Fujiwara Y; Xie H; Klusmann JH; Orkin SH; Li Z
Stem Cells; 2017 Jul; 35(7):1773-1785. PubMed ID: 28436588
[TBL] [Abstract][Full Text] [Related]
13. MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation.
Huang Y; Thoms JA; Tursky ML; Knezevic K; Beck D; Chandrakanthan V; Suryani S; Olivier J; Boulton A; Glaros EN; Thomas SR; Lock RB; MacKenzie KL; Bushweller JH; Wong JW; Pimanda JE
Leukemia; 2016 Jul; 30(7):1552-61. PubMed ID: 27055868
[TBL] [Abstract][Full Text] [Related]
14. The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice.
Li Y; Vecchiarelli-Federico LM; Li YJ; Egan SE; Spaner D; Hough MR; Ben-David Y
Blood; 2012 May; 119(19):4486-98. PubMed ID: 22451425
[TBL] [Abstract][Full Text] [Related]
15. ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation.
Knudsen KJ; Rehn M; Hasemann MS; Rapin N; Bagger FO; Ohlsson E; Willer A; Frank AK; Søndergaard E; Jendholm J; Thorén L; Lee J; Rak J; Theilgaard-Mönch K; Porse BT
Genes Dev; 2015 Sep; 29(18):1915-29. PubMed ID: 26385962
[TBL] [Abstract][Full Text] [Related]
16. TLS-ERG leukemia fusion protein deregulates cyclin-dependent kinase 1 and blocks terminal differentiation of myeloid progenitor cells.
Pan J; Zou J; Wu DY; Roberson RS; Hennings LJ; Ma X; Yared M; Blackburn ML; Chansky HA; Yang L
Mol Cancer Res; 2008 May; 6(5):862-72. PubMed ID: 18505930
[TBL] [Abstract][Full Text] [Related]
17. The leukemia stem cell.
Estrov Z
Cancer Treat Res; 2010; 145():1-17. PubMed ID: 20306242
[No Abstract] [Full Text] [Related]
18. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.
Lucena-Araujo AR; Coelho-Silva JL; Pereira-Martins DA; Thomé C; Scheucher PS; Lange AP; Paiva HH; Hemmelgarn BT; Morais-Sobral MC; Azevedo EA; Franca-Neto PL; Franca RF; Silva CL; Krause A; Rego EM
Oncotarget; 2017 Jan; 8(5):8475-8483. PubMed ID: 28035072
[TBL] [Abstract][Full Text] [Related]
19. Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.
Zhang J; McCastlain K; Yoshihara H; Xu B; Chang Y; Churchman ML; Wu G; Li Y; Wei L; Iacobucci I; Liu Y; Qu C; Wen J; Edmonson M; Payne-Turner D; Kaufmann KB; Takayanagi SI; Wienholds E; Waanders E; Ntziachristos P; Bakogianni S; Wang J; Aifantis I; Roberts KG; Ma J; Song G; Easton J; Mulder HL; Chen X; Newman S; Ma X; Rusch M; Gupta P; Boggs K; Vadodaria B; Dalton J; Liu Y; Valentine ML; Ding L; Lu C; Fulton RS; Fulton L; Tabib Y; Ochoa K; Devidas M; Pei D; Cheng C; Yang J; Evans WE; Relling MV; Pui CH; Jeha S; Harvey RC; Chen IL; Willman CL; Marcucci G; Bloomfield CD; Kohlschmidt J; Mrózek K; Paietta E; Tallman MS; Stock W; Foster MC; Racevskis J; Rowe JM; Luger S; Kornblau SM; Shurtleff SA; Raimondi SC; Mardis ER; Wilson RK; Dick JE; Hunger SP; Loh ML; Downing JR; Mullighan CG;
Nat Genet; 2016 Dec; 48(12):1481-1489. PubMed ID: 27776115
[TBL] [Abstract][Full Text] [Related]
20. The role of microRNA-196a and microRNA-196b as ERG regulators in acute myeloid leukemia and acute T-lymphoblastic leukemia.
Coskun E; von der Heide EK; Schlee C; Kühnl A; Gökbuget N; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Leuk Res; 2011 Feb; 35(2):208-13. PubMed ID: 20570349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
